How is Synagis stored?

Upon receipt and until reconstitution for use, Synagis® (palivizumab) should be stored between 2 and 8°C (35.6° and 46.4°F) in its original container. Do not freeze. Do not use beyond the expiration date.

How do you administer a Synagis injection?

Synagis should be administered in a dose of 15 mg per kg intramuscularly using aseptic technique, preferably in the anterolateral aspect of the thigh. The gluteal muscle should not be used routinely as an injection site because of the risk of damage to the sciatic nerve.

How much does the Synagis shot cost?

under the brand name Synagis, can cost up to $6,000 for five treatments, given to at-risk children in monthly intramuscular injections during RSV season. The company is pushing for wider use, but researchers are divided over its benefits and over when and to whom it should be administered.

How do you give the RSV vaccine?

How is it given? Synagis is given as an intramuscular injection into the muscle of the thigh. Your baby will have an injection of palivizumab once a month between October and February, up to a maximum of 5 injections.

When does Synagis season end?

Aetna considers Synagis season to be from November 1st to March 31st. Other health plans may differ.

Can you give Synagis with other vaccines?

Palivizumab is not a vaccine and therefore it does not interact with other vaccines (including live attenuated vaccines i.e., MMR and Varicella) and can be safely administered concomitantly with routine childhood vaccines if the child is well and not febrile.

Is Synagis given IM?

SYNAGIS® (palivizumab) should be administered in a dose of 15 mg/kg via IM injection using aseptic technique, preferably in the anterolateral aspect of the thigh.

How much is Synagis out of pocket?

The cost for Synagis intramuscular solution (100 mg/mL) is around $1,724 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Is Synagis covered by insurance?

Synagis is covered under the member’s medical benefit. For the 2019-2020 RSV season, it is mandatory for all participating providers to obtain Synagis for Independence members through PerformSpecialty®, an independent company.

What type of vaccine is Synagis?

SYNAGIS, 50 mg and 100 mg for injection, is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children: born prematurely (at or before 35 weeks) and who are 6 months of age or less at the beginning of RSV season.